Cover Image
市場調查報告書

全球幹細胞技術、應用市場預測

Stem Cell Technologies & Applications Market Forecast 2016-2021

出版商 Labrinth Analytics LTD 商品編碼 359778
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
全球幹細胞技術、應用市場預測 Stem Cell Technologies & Applications Market Forecast 2016-2021
出版日期: 2016年04月05日 內容資訊: 英文
簡介

本報告提供全球幹細胞技術、應用市場相關調查分析,趨勢與收益 (成果、預測) 、推動因素、阻礙因素,機會與課題等系統性資訊。

第1章 過去的資料

第2章 報告概要

第3章 全球幹細胞技術、應用市場主要企業

  • Nuvasive, Inc.
  • Orthofix International N.V.,
  • MEDIPOST
  • Athersys, Inc.
  • Celgene Corporation
  • Vericel Corporation
  • Novartis
  • Brainstorm Cell Therapeutics Inc.
  • Anterogen
  • Gamida Cell Ltd.
  • RTI Surgical, Inc.

第4章 幹細胞技術、應用市場:各類型

  • 收益預測
  • 市場預測
  • 成體幹細胞
  • ES細胞
  • 市場佔有率:各市場區隔

第5章 幹細胞技術、應用市場:各用途

  • 收益預測
  • 癌症
  • CVD
  • CNS
  • 其他
  • 市場佔有率:各用途

第6章 主要國家的幹細胞技術、應用市場

  • 北美市場
  • 美國
  • 加拿大
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 其他的歐洲市場
  • 日本
  • 中國
  • 印度
  • 其他亞洲市場
  • 巴西
  • 墨西哥
  • 其他南美市場
  • 其他地區市場

第7章 幹細胞技術、應用市場定性分析

  • 幹細胞概要
  • 美國的幹細胞研究的時間軸
  • 幹細胞相關各種法規 (美國、歐洲、日本、印度)
  • 推動市場要素
  • 市場障礙
  • SWOT分析
  • 大環境分析

第8章 表格的清單

第9章 圖的清單

第10章 企業、其他刊載企業

目錄

The stem cell technologies and applications market will witness significant growth during 2016-2021, driven by primarily product innovation and technological innovations. The global stem cell technologies and applications market was valued at US$ XXXX m in 2015 and is expected to reach US$ XXXX m, at a CAGR of XXXX % during 2016-2021. The U.S. was the largest market for stem cell technologies and applications, accounted for XXXX % of the global market. Asian countries, particularly China and India are proving to be attractive market during the forecast period from 2016 to 2021.

image1

Adult stem cell was the largest segment in terms of revenue in the global stem cell technologies and applications market and accounted for XXXX % share in 2015. Rising demand for adult stem cells, technological innovations by the market players, mergers and acquisitions and growing healthcare infrastructure in the developing nations will boost market growth in the future. Moreover, it is observed that embryonic stem cell is expanding at a highest CAGR during the forecast period from 2016 to 2021. Furthermore, due to the presence of a number of market giants with similar business strategy it is expected that competitive rivalry for the stem cell technologies and applications market will increase in the future

image2

The global stem cell technologies and applications market by application has been segmented as cancer, CVD, CNS and others. Likewise, the global market for stem cell technologies and applications has been segmented in the following geographic regions North America, Europe, Asia, Latin America and rest of the World. Country wise the market is segmented as the U.S., Japan, Germany, China, France, United Kingdom, Italy, Spain, India, Brazil, Mexico and rest of the world.

This report provides market share and analysis for all the above mentioned regions from 2015 to 2021, and forecasted from 2016 to 2021, considering 2015 as base year.

image3

image4

image5

image6

Table of Contents

  • Report Summary
  • Introduction to Stem Cell Technologies and Applications Market 2015
  • What information can you expect to gain from this report?
  • Market Segmentation
  • Leading National Market for Stem Cell Technologies and Applications

1. Historical Data

  • 1.1 Stem Cell Technologies Market 2012
  • 1.2 Stem Cell Technologies Market 2013
  • 1.3 Stem Cell Technologies Market 2014
  • 1.4 Stem Cell Technologies Market 2015

2. Report Overview

  • 2.1 Global Overview of the Stem Cell Technologies and Applications Market 2015
  • 2.2 Market Segmentation
  • 2.3 Market Share by regional Markets
  • 2.4 Leading National Market for Stem Cell Technologies and Applications

3. Leading Companies in the World Stem Cell Technologies and Applications Market

  • 3.1 Nuvasive, Inc.
  • 3.2 Orthofix International N.V.,
  • 3.3 MEDIPOST
  • 3.4 Athersys, Inc.
  • 3.5 Celgene Corporation
  • 3.6 Vericel Corporation
  • 3.7 Novartis
  • 3.8 Brainstorm Cell Therapeutics Inc.
  • 3.9 Anterogen
  • 3.10 Gamida Cell Ltd.
  • 3.11 RTI Surgical, Inc.

4. Stem Cell Technologies and Applications Market by Type, 2015 - 2021

  • 4.1 The World Stem Cell Technologies and Applications Market: Revenue Forecasts 2016-2021
  • 4.2 Glass Stem Cell Technologies and Applications Market Forecast 2016 - 2021
  • 4.3 Adult Stem Cell Market Forecast 2016 - 2021
  • 4.4 Embryonic Stem Cell Market Forecast 2016 - 2021
  • 4.5 Market Share by Segments, 2015

5. Stem Cell Technologies and Applications Market by Applications, 2015 - 2021

  • 5.1 The World Stem Cell Technologies and Applications Market: Revenue Forecasts 2016-2021
  • 5.2 Cancer Stem Cell Application Market Forecast 2016 - 2021
  • 5.3 CVD Stem Cell Application Market Forecast 2016 - 2021
  • 5.4 CNS Stem Cell Application Market Forecast 2016 - 2021
  • 5.5 Others Stem Cell Application Market Forecast 2016 - 2021
  • 5.6 Market Share by Applications, 2015

6. Leading National Markets for the Stem Cell Technologies and Applications, 2016-2021

  • 6.1 North America Stem Cell Technologies and Applications Market: Regional Forecast 2016-2021
  • 6.2 The US Stem Cell Technologies and Applications Market Forecast 2016-2021
  • 6.3 The Canada Stem Cell Technologies and Applications Market Forecast 2016-2021
  • 6.4 The Germany Stem Cell Technologies and Applications Market Forecast 2016-2021
  • 6.5 The France Stem Cell Technologies and Applications Market Forecast 2016-2021
  • 6.6 The U.K. Stem Cell Technologies and Applications Market Forecast 2016-2021
  • 6.7 The Italy Stem Cell Technologies and Applications Market Forecast 2016-2021
  • 6.8 The Spain Stem Cell Technologies and Applications Market Forecast 2016-2021
  • 6.9 The rest of Europe Stem Cell Technologies and Applications Market Forecast 2016-2021
  • 6.10 The Japan Stem Cell Technologies and Applications Market Forecast 2016-2021
  • 6.11 The China Stem Cell Technologies and Applications Market Forecast 2016-2021
  • 6.12 The India Stem Cell Technologies and Applications Market Forecast 2016-2021
  • 6.13 The rest of Asia Stem Cell Technologies and Applications Market Forecast 2016-2021
  • 6.14 The Brazil Stem Cell Technologies and Applications Market Forecast 2016-2021
  • 6.15 The Mexico Stem Cell Technologies and Applications Market Forecast 2016-2021
  • 6.16 The rest of Latin America Stem Cell Technologies and Applications Market Forecast 2016-2021
  • 6.17 The rest of the World Stem Cell Technologies and Applications Market Forecast 2016-2021

7. Qualitative Analysis of the Stem Cell Technologies and Applications Market, 2016-2026

  • 7.1 Overview of Stem Cells
  • 7.2 Timelines for Stem Cell Research in the U.S.
  • 7.3 Various Regulations Pertaining to Stem Cells (U.S., Europe, Japan, India)
  • 7.4 Market Drivers
  • 7.5 Market Barriers
  • 7.6 SWOT Analysis
  • 7.7 PESTEL Analysis

8. List of Tables

  • Table 1 Nuvasive: Historical Sales ($m, AGR%), 2010-2014
  • Table 2 Nuvasive: Revenue Share by Region, 2014
  • Table 3 Nuvasive: Revenue Share by Segment, 2014
  • Table 4 Orthofix: Historical Sales ($m, AGR%), 2010-2014
  • Table 5 Orthofix: Revenue Share by Region, 2014
  • Table 6 Medipost: Historical Sales ($m, AGR%), 2010-2014
  • Table 7 Athersys, Inc.: Historical Sales ($m, AGR%), 2010-2014
  • Table 8 Celgene: Historical Sales ($m, AGR%), 2010-2014
  • Table 9 Celgene: Revenue Share by Region, 2014
  • Table 10 Celgene: Revenue Share by Region, 2014
  • Table 11 Celgene: Revenue Share by Segment, 2014
  • Table 12 Vericel: Historical Sales ($m, AGR%), 2010-2014
  • Table 13 Vericel: Revenue Share by Segment, 2014
  • Table 14 Novartis: Historical Sales ($m, AGR%), 2010-2014
  • Table 15 Novartis: Revenue Share by Region, 2014
  • Table 16 RTI Surgical: Historical Sales ($m, AGR%), 2010-2014
  • Table 17 RTI Surgical: Revenue Share by Region, 2014
  • Table 18 RTI Surgical: Revenue Share by Segment, 2014
  • Table 19 North America Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016- 2021
  • Table 20 The U.S. Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 21 Canada Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 22 Europe Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 23 Russia Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 24 Germany Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 25 France Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 26 U.K. Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 27 Italy Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 28 Spain Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 29 Rest of Europe Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 30 Asia Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 31 Japan Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 32 China Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 33 India Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 34 Rest of Asia Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 35 Latin America Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 36 Brazil Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 37 Mexico Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 48 Rest of Latin America Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 39 Rest of the World Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 40 Market Share Analysis by Country, 2015 (%)
  • Table 41 Pipeline and Marketed Product List
  • Table 42 Porter's Analysis
  • Table 43 PESTEL Analysis

7 Lists of Figures

  • Figure 1 Popular Soutce of Stem Cells, 2014
  • Figure 2 Stem Cell technologies and Applications Market, Regional Market Share 2015
  • Figure 3 Global Stem Cell technologies and Applications Market Segmentation Overview, 2015
  • Figure 4 Nuvasive, Inc.: Historical Sales ($m, AGR%), 2011-2014
  • Figure 5 Nuvasive: Revenue Share by Geography, 2014
  • Figure 6 Nuvasive: Revenue Share by Segment, 2014
  • Figure 7 Orthofix: Historical Sales ($m, AGR%), 2010-2014
  • Figure 8 Orthofix: Revenue Share by Geography, 2014
  • Figure 9 Orthofix: Revenue Share by Segment, 2014
  • Figure 10 Athersys: Historical Sales ($m, AGR%), 2010-2014
  • Figure 11 Celgene: Historical Sales ($m, AGR%), 2010-2014
  • Figure 12 Celgene: Revenue Share by Geography, 2014
  • Figure 13 Vericel: Historical Sales ($m, AGR%), 2010-2014
  • Figure 14 Novartis: Historical Sales ($m, AGR%), 2010-2014
  • Figure 15 Novartis: Revenue Share by Region, 2014
  • Figure 16 RTI Surgical: Historical Sales ($m, AGR%), 2010-2014
  • Figure 17 RTI Surgical: Revenue Share by Geography, 2014
  • Figure 18 RTI Surgical: Revenue Share by Segment, 2014
  • Figure 19 North America Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 20 The U.S. Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 21 Canada Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 22 Europe Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 23 Russia Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 24 Germany Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 25 France Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 26 U.K. Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 27 Italy Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 28 Spain Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 29 Rest of Europe Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 30 Asia Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 31 Japan Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 32 China Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 33 India Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Table 34 Rest of Asia Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 35 Latin America Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 36 Brazil Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 37 Mexico Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 38 Rest of Latin America Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 39 Rest of the World Forecast, Revenue ($m), Annual Growth (%), CAGR (%), 2016-2021
  • Figure 40 Market Share Analysis by, Country (%)

8 Companies and Other Organizations Mentioned

  • EMA (European Medicines Agency)
  • FDA (US Food and Drug Administration)
  • GlaxoSmithKline (GSK)
  • Merck & Co.
  • MHLW (Ministry of Health, Labour, and Welfare)
  • MHRA (Medicines and Healthcare Products Regulatory Agency)
  • NICE (the National Institute for Health and Care Excellence)
  • Nuvasive, Inc.
  • Orthofix International
  • MEDIPOST
  • Athersys, Inc.
  • Celgene Corporation
  • Vericel Corporation
  • Novartis
  • Brainstorm Cell Therapeutics Inc.
  • Anterogen
  • Gamida Cell Ltd.
  • RTI Surgical WHO (World Health Organization)
  • Aastrom Biosciences
  • Adistem
  • Advanced Cell Technology
  • Alder Biopharmaceuticals
  • Alkems
  • AllCells
  • Allergan
  • AlloSource
  • American Academy of Neurology
  • American Academy of Pediatrics (AAP)
  • American Society of Blood and Marrow Transplantation.
  • Americord
  • Amgen
  • Angiocrine Bioscience
  • Anterogen
  • Antria
  • Apceth
  • Asterias Biotherapeutics
  • Athersys
  • Auriga Ventures
  • Axiogenesis
  • Baxter Healthcare
  • BaYi Brain Hospital
  • BioCardia
  • BioE
  • BioEden
  • Biogenea-Cellgenea
  • Bioheart, Inc
  • Biologic Therapies
  • Biomatrica
  • BioMet Orthopedics
  • Biotec Services International
  • Blackstone Medical
  • BrainStorm Cell Therapeutics
  • Caladrius Biosciences
  • California Institute for Regenerative Medicine (CIRM)
  • Calimmune
  • Capricor
  • Cell Cure Neurosciences
  • Cell Therapy Catapult
  • Cellular Biomedicine Group (CBMG)
  • Cellular Dynamics International
  • Center for International Blood and Marrow Transplant Research (CIBMTR)
  • Centers for Medicare & Medicaid Services
  • Cephalon Cesca Therapeutics
  • Ceylad Cha General Hospital
  • China Cord Blood Corporation
  • China Food and Drug Administration (CFDA)
  • Chinese Academy of Sciences
  • Chinese Ministry of Health
  • Clal Biotechnologies Industries
  • Cleveland Biolabs
  • Clinicaltrials.gov
  • ClinImmune Labs
  • Centers for Medicare & Medicaid Services
  • Denali Ventures Dendreon Dong-A Pharmaceuticals
  • Drugs and Cell Therapies in Haematology (Journal)
  • Elbit Medical Technologies
  • Eli Lilly
  • Elsevier
  • EpiStem
  • ESI Bio
  • European Court of Human Rights European Court of Justice

Many More...

Back to Top